Michael Bumby
Director/Miembro de la Junta en MEDIPHARM LABS CORP. .
Fortuna: 6 984 $ al 30/04/2024
Cargos activos de Michael Bumby
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MEDIPHARM LABS CORP. | Director/Miembro de la Junta | 01/04/2023 | - |
Trimel Biopharma, Inc.
 Trimel Biopharma, Inc. BiotechnologyHealth Technology Part of Acerus Pharmaceuticals Corp., Trimel Biopharma, Inc. develops biopharmaceutical products. The company is based in Mississauga, Canada. | Director Financiero/CFO | 03/08/2015 | - |
| reBOOT Canada | Director/Miembro de la Junta | 01/09/2013 | - |
Historial de carrera de Michael Bumby
Antiguos cargos conocidos de Michael Bumby.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACERUS PHARMACEUTICALS CORPORATION | Director Financiero/CFO | 03/08/2015 | 01/06/2016 |
| ANTIBE THERAPEUTICS INC. | Director Financiero/CFO | 01/01/2013 | 01/08/2015 |
| Contacto de Relaciones con Inversores | 01/01/2013 | 01/08/2015 | |
Antibe Holdings, Inc.
 Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Director Financiero/CFO | 01/12/2012 | 01/07/2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/03/2000 | 01/04/2011 |
Merus Labs, Inc.
 Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Part of Norgine Europe BV, Merus Labs, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Vancouver, Canada. The company was founded by Penny White, Ahmad Doroudian. Paul William Pay has been the CEO of the company since 2017. Merus Labs was acquired by Range Gold Corp. on March 26, 2010. | Director Financiero/CFO | - | - |
| VIVO CANNABIS INC. | Director/Miembro de la Junta | 05/07/2021 | 21/12/2021 |
| Director Financiero/CFO | 01/12/2017 | - | |
| Contacto de Relaciones con Inversores | - | - | |
| Secretario Corporativo | - | - | |
| ░░░░░░░░ ░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
Formación de Michael Bumby.
| University of Guelph | Doctorate Degree |
| University of Toronto | Masters Business Admin |
Estadísticas
Internacional
| Canadá | 13 |
| Estados Unidos | 2 |
Operativa
| Director of Finance/CFO | 7 |
| Investor Relations Contact | 3 |
| Director/Board Member | 3 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 3 |
| Process Industries | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ANTIBE THERAPEUTICS INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| MEDIPHARM LABS CORP. | Process Industries |
| Empresas privadas | 8 |
|---|---|
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
Trimel Biopharma, Inc.
Trimel Biopharma, Inc. BiotechnologyHealth Technology Part of Acerus Pharmaceuticals Corp., Trimel Biopharma, Inc. develops biopharmaceutical products. The company is based in Mississauga, Canada. | Health Technology |
Merus Labs International, Inc.
 Merus Labs International, Inc. Pharmaceuticals: MajorHealth Technology Merus Labs International, Inc. wass a pharmaceutical company. It was engaged in the acquisition of mature prescription and over the counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and it was headquartered in Vancouver, Canada. | Health Technology |
Antibe Holdings, Inc.
Antibe Holdings, Inc. Financial ConglomeratesFinance Part of Antibe Therapeutics, Inc., Antibe Holdings, Inc. is a Canadian company that functions as an investment holding company. The company is based in Toronto, Canada. Antibe Holdings was acquired by Antibe Therapeutics, Inc. on June 03, 2021 for $19.02 million. Daniel Legault has been the CEO of the company since 2005. | Finance |
| reBOOT Canada | |
| Bluenose & Co. | |
VIVO Cannabis, Inc.
 VIVO Cannabis, Inc. Agricultural Commodities/MillingProcess Industries VIVO Cannabis, Inc. is a capital pool company, which engages in the production, sales, and research licenses from Health Canada; and operates indoor cultivation facilities. It operates through the following segments: Craft Cannabis Product, Medical Cannabis Clinic, and Corporate and International. The Craft Cannabis Product segment focuses on producing and selling cannabis and cannabis-derived products for direct sale to medical patient and for the adult-use market. The Medical Cannabis Clinic segment is involved and operated by its indirect wholly-owned subsidiary, Harvest Medicine Inc. The Corporate segment includes non-production related corporate activities and international operations. The company was founded by Ken Clement on April 12, 2007 and is headquartered in Toronto, Canada. | Process Industries |
Merus Labs, Inc.
Merus Labs, Inc. Pharmaceuticals: MajorHealth Technology Part of Norgine Europe BV, Merus Labs, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Vancouver, Canada. The company was founded by Penny White, Ahmad Doroudian. Paul William Pay has been the CEO of the company since 2017. Merus Labs was acquired by Range Gold Corp. on March 26, 2010. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Bumby
- Experiencia
